Processa Pharmaceuticals

Historical price data

Processa Pharmaceuticals is a clinical-stage biopharma focused on improving survival and quality of life for patients with life-threatening or life-compromising chronic diseases. Its core strategy involves applying a proprietary regulatory science methodology to de-risk and accelerate the development of acquired or in-licensed clinical-stage drug candidates, aiming for higher probability of success and capital efficiency. The leadership team, with a collective history of over 30 years, claims involvement in the approval of more than 30 FDA drugs, forming the foundation of its patient-centric development model.

A proprietary Regulatory Science and Development methodology, not a discovery platform. It is a process-oriented framework leveraging deep regulatory intelligence and clinical trial design expertise to de-risk and accelerate the development of acquired drug candidates.

Competition varies by program, from first-in-disease potential in necrobiosis lipoidica to crowded markets in oncology and gastroenterology. Processa's primary differentiation is its regulatory science platform, competing with other development-focused biotechs on the basis of execution efficiency and regulatory acumen rather than novel discovery.